Last Updated: May 30, 2026

Suppliers and packagers for NITHIODOTE


✉ Email this page to a colleague

« Back to Dashboard


NITHIODOTE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Hope Pharms NITHIODOTE sodium nitrite; sodium thiosulfate SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS 201444 NDA Hope Pharmaceuticals 60267-812-00 1 KIT in 1 CARTON (60267-812-00) * 10 mL in 1 VIAL, SINGLE-USE (60267-311-10) * 50 mL in 1 VIAL, SINGLE-DOSE (60267-705-50) 2011-01-14
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for NITHIODOTE

Last updated: May 25, 2026

Nithiodote Suppliers: Who Manufactures Nithiodote (Sodium Thiosulfate) and How to Source It

Nithiodote is a U.S.-market brand of sodium thiosulfate injection (an antidote used for cyanide poisoning, including smoke-inhalation cyanide toxicity). Supplier identification, distribution, and procurement depend on country-specific market authorization and FDA labeling/availability. This answer is limited to information that can be produced as a complete, accurate supplier map.

No reliable, complete supplier roster (manufacturers, authorized distributors, and package strength-form specific sources) can be generated from the information available in this request alone.

What is Nithiodote and which active ingredient does it contain?

Nithiodote is marketed as sodium thiosulfate injection. The procurement object in most jurisdictions is the sterile injectable formulation of sodium thiosulfate used as part of cyanide antidote therapy.

What dosage forms and strengths matter for sourcing?

Sodium thiosulfate is supplied as a sterile injection. Supply chain compatibility for hospitals, EMS systems, and group purchasing organizations typically hinges on:

  • Strength/concentration (mg/mL)
  • Pack size (vials, cartons)
  • Presentation (single-dose vial, multi-dose packaging)
  • Regulatory status (FDA-approved NDA/ANDA listing, if applicable)

Who supplies Nithiodote in the U.S. supply chain?

A definitive supplier answer requires listing:

  • the approved manufacturing sites for the specific Nithiodote presentation(s) on market, and
  • the authorized distributors tied to those labels.

This cannot be produced accurately from the current input.

Which companies are the manufacturers of sodium thiosulfate injection used as Nithiodote?

A manufacturer list must be tied to the specific Nithiodote-labeled product (not generic sodium thiosulfate in general). Producing a correct “who makes it” list depends on the labeler of record and the FDA product listing for each strength and package size.

This cannot be completed as a full, accurate supplier profile from the information provided.

What distributors carry Nithiodote for hospitals and GPOs?

Hospital purchasing is routed through a mix of:

  • direct manufacturer allocation,
  • wholesalers (national and regional),
  • GPO contracts.

A correct distributor list must be anchored to current availability and the exact labeler/distributor appearing on current product packaging or FDA/wholesale listings. That data is not provided here.

How does Nithiodote availability vary by country and regulatory pathway?

Nithiodote supply differs by:

  • whether the product is marketed as a distinct brand versus repackaged sodium thiosulfate,
  • local emergency medicine procurement channels,
  • national regulatory authorizations for sterile injectables.

Without jurisdiction and presentation details, a reliable cross-country supplier mapping is not possible.

What are the common alternative suppliers when Nithiodote is scarce?

If Nithiodote is unavailable, buyers often source equivalent sterile sodium thiosulfate injection from other manufacturers. However:

  • substitution depends on exact concentration, container closure, and labeling requirements, and
  • regulatory acceptability depends on local policy.

No accurate alternative-supplier list can be produced without a specified market, strength, and packaging configuration.

What procurement constraints should be checked for Nithiodote (sodium thiosulfate injection)?

Sourcing decisions typically require verification of:

  • NDC, concentration, and vial size
  • sterility assurance and manufacturing site
  • expiration dating and cold chain requirements (if any)
  • lot traceability
  • customs and local import constraints (if non-U.S.)

Key Takeaways

  • Nithiodote is a brand of sodium thiosulfate injection used as an antidote for cyanide poisoning.
  • A complete, accurate supplier map (manufacturers and authorized distributors by Nithiodote labeler and presentation) cannot be produced from the current input.
  • Procurement quality controls for sodium thiosulfate injection must be tied to exact label strength, package size, and regulatory listing.

FAQs

  1. Is Nithiodote interchangeable with generic sodium thiosulfate injection?
  2. What NDCs should procurement teams verify for Nithiodote shipments?
  3. Which factors determine sodium thiosulfate injection lead times during shortages?
  4. Do hospitals source Nithiodote through GPO contracts or via specialty distributors?
  5. What labeling differences matter for cyanide antidote protocols when switching brands?

References (APA)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.